Comments on the Letter "Bridging the Gap: The Critical Next Steps for Implementing Genetic Risk Scores in Myocardial Infarction Prevention in Saudi Arabia". [PDF]
J Saudi Heart AssocSaeed A.
europepmc +1 more source
Clinical and Translational Science, Volume 19, Issue 8, August 2026.ABSTRACT The NAT2 gene encodes N‐acetyltransferase 2, an enzyme critically involved in the biotransformation of numerous xenobiotics and aromatic amines, including isoniazid, a cornerstone drug in tuberculosis therapy. Genetic polymorphisms in NAT2 lead to variable acetylation rates, clinically categorized as poor, intermediate, or rapid metabolizer ...
Nada Benyahya +6 more
wiley +1 more source
Cancer patients' perspectives and practices regarding pharmacogenomic testing and its cost. [PDF]
Front PharmacolDweib M, Hallak H, Hour H.
europepmc +1 more source
Clinical and Translational Science, Volume 19, Issue 8, August 2026.ABSTRACT CYP2C19 plays an important role in the metabolism of many medications, including the antiplatelet agent clopidogrel, the antifungal agent voriconazole, selective serotonin reuptake inhibitors, select tricyclic antidepressants, and proton pump inhibitors.
Amy J. Turner +8 more
wiley +1 more source
Pharmacogenomics knowledge and implementation readiness among community pharmacists in Jordan: A national cross-sectional study. [PDF]
PLoS OneAl-Kubaisi KA +4 more
europepmc +1 more source
ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice. [PDF]
ToxicsBožina T +6 more
europepmc +1 more source
Operationalizing Next-Generation Sequencing in a Community-Based Academic Cancer Center: Workflow, Integration, and Impact. [PDF]
Cancers (Basel)Moorthy G +19 more
europepmc +1 more source
The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke. [PDF]
Pharmacogenomics JDeiman B +4 more
europepmc +1 more source